跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEMGLEE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SEMGLEE
Authorized
STANDARD
SEMGLEE
biocon sdn.bhd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ea2b155bcf53f644
Company
biocon sdn.bhd
Type
Standard
Approval Details
Approval Id
ea2b155bcf53f644
Drug Approval Canada Name
SEMGLEE
Product Name
SEMGLEE
Status
Marketed
Status Date
2024-07-12
Original Market Date
2022-10-14
Din
02526441
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D
Ahfs
68:20.08
Atc Original
A10AE04 INSULIN GLARGINE
Atc Name
a 10 ae 04
Aig Number
0147062001
Company Name
biocon sdn.bhd
Company Address
No. 1, Jalan Bioteknologi 1, Kawasan Perindustrian Silc, Iskandar Puteri, Johor, Malaysia, 79200
Active Ingredients
INSULIN GLARGINE
100 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ea2b155bcf53f644
Type
Standard
Back to Health Canada Approvals